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ed.2012.Abstract Objective: The success of long-term maintenance therapy for hypertension depends lar-
gely on the patient’s compliance with a therapeutic plan. The objective of this study was to deter-
mine the compliance with treatment of hypertensive patients attending primary health care centres
in Almadinah Almunawwarah, Kingdom of Saudi Arabia.
Methods: A community-based cross-sectional study was adopted, with cluster random sampling.
Sociodemographic data and subjective information were collected at interviews and clinical data by
reviewing patients’ medical records.
Results: The total mean percentage score for compliance was 35.1%. The best compliance was
with electrocardiography and Doppler scanning, followed by laboratory investigations; the worst
compliance was with exercise. In general, patients showed poor compliance with exercise and die-
tary regimes. The factors that affected patients’ compliance were their sex, level of education, work
status, smoking habits, self-reported response to medications and their perception of hypertension.
A satisfactory patient–physician relationship was reported by only 14.4% of patients with fair-to-
good compliance; 83.0% of patients with associated co-morbidity had poor compliance.
Conclusion: A healthy lifestyle, patient education, family counselling and social support net-
works should be strengthened in health promotion programmes in order to enhance compliance
of hypertensive patients with the therapeutic regimen and to improve their quality of life.
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11.004Introduction
Hypertension is a common chronic problem worldwide. It is
deﬁned as systolic blood pressure P140 mm Hg and/or dia-
stolic blood pressure P90 mm Hg and/or receiving antihyper-
tensive medication. Its prevalence differs from one country to
another. In 2000, nearly 1 billion people or 26% of the adult
population worldwide had hypertension, and it was common
in both developed (333 million) and underdeveloped (639 mil-
lion) countries.1 Over 90–95% of adult hypertension is of the
essential type.2Ltd. All rights reserved.
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population.3 Epidemiological studies in Arab countries show
prevalences ranging from 20.1% in Egypt, 26.3% in Kuwait,
32.1% in Qatar and 33% in Oman.4–7 A recent study in the
Kingdom of Saudi Arabia found that 26% of adults were
hypertensive.8
Hypertension is a major risk factor for stroke and coro-
nary heart disease.9,10 A large percentage of the population,
however, are unaware that they have hypertension, and those
known to be hypertensive are often not adequately con-
trolled.11–13 The ﬁrst line of treatment for hypertension is pre-
ventive lifestyle changes and medication,14,15 and poor control
is attributed to poor compliance with the treatment
regime.16–18 Sackett and Haynes19 deﬁned patient compliance
as ‘‘the extent to which a person’s behaviour in terms of tak-
ing medication, following diet, or executing life-style changes
coincides with medical or health advice.’’ Compliance can be
viewed as a patient’s behaviour in terms of timeliness in seek-
ing care, attendance at follow-up appointments or observance
of the physician’s advice. As compliance improves the out-
come of hypertension, understanding its pattern is an impor-
tant step in evaluating the effect of a hypertension treatment
regime.
The objective of this study was to determine the compliance
of patients with hypertension with their treatment regime.Table 1: Socio-demographic and disease characteristics of hypertensive
Characteristic Level of compliance
Poor
N= 760 %
Age in years: mean (SD) 47.4 (12.51)
Sex
Male 370 80.3
Female 390 88.8
Education
No formal education 24 72.7
Basic 117 86.0
High 619 84.7
Work status
Not working 239 78.4
Working 521 87.6
Marital status
Single 168 85.3
Married 314 86.5
Widow 157 84.0
Divorced 121 79.1
Smoking
Non-smoker 121 90.3
Active smoker 382 88.2
Passive smoker 257 77.2
Self-reported response to medication
Not responding 214 79.0
Responding 546 86.8
Co-morbid conditions
Absent 267 87.3
Present 493 83.0
Duration of hypertension (years): mean (SD) 4.6 (3.14)
a Pearson’s chi-square test, p< 0.05; P value of Student’s t test.Materials and Methods
A community-based cross-sectional study was performed, with
random sampling of 30 clusters in the Medina City administra-
tive divisions and random selection of one primary health care
centre from each cluster. At each primary health care centre,
30 hypertensive patients aged P20 years with a diagnosis of
hypertension who were being investigated or treated were se-
lected during a 5-month period starting in October 2011. All
900 hypertensive patients gave verbal consent for inclusion in
the study. Data were collected by interview with a question-
naire designed to elicit sociodemographic data (basic educa-
tion including primary and preparatory level, higher
education including secondary level and university degree or
more), clinical data including concurrent diseases such as dia-
betes, heart disease and rheumatic disorders, views on health
care services, the patient’s beliefs and perceptions concerning
hypertension, compliance with the treatment regime and barri-
ers to good compliance.
Patient compliance was assessed from their attendance,
according to the WHO guidelines.16 Fair-to-good compliance
was recorded when the patient attended the clinic for periodic
medical check-ups and blood pressure measurement on more
than two occasions during 6 months and annual check-ups
for eye and renal screening. Poor compliance was recordedpatients by compliance level.
Total P value
Fair to good
N= 140 % N= 900
46.9 (12.18) 47.3 (12.46) NS
91 19.7 461 100.0 < 0.05a
49 11.2 439 100.0
9 27.3 33 100.0 < 0.05a
19 14.0 136 100.0
112 15.3 731 100.0
66 21.6 305 100.0 < 0.05a
74 12.4 595 100.0
29 14.7 197 100.0 NS
49 13.5 363 100.0
30 16.0 187 100.0
32 20.9 153 100.0
13 9.7 134 100.0 < 0.05a
51 11.8 433 100.0
76 22.8 333 100.0
57 21.0 271 100.0 <0.05a
83 13.2 629 100.0
39 12.7 306 100.0 NS
101 17.0 594 100.0
4.4 (2.69) 4.6 (3.07) NS
94 Compliance with treatment of patients with hypertension in Almadinah Almunawwarah: A community-based studywhen the patient had not attended the clinic during the previ-
ous 6 months.
To assess outcome of care, the patients’ medical records
were reviewed during their interview to obtain the most recent
blood pressure measurements and any complications. Body
mass index, pulse and blood pressure were estimated.
A compliance score was calculated for each patient and
converted to a total percentage score, categorized as poor
(<62.5%), fair (62.5–80.0%) or good (>80.0%). The mean
score was estimated for each item, and the total mean percent-
age score was calculated for each category. In order to study
the relations between degree of compliance and the study vari-
ables, two levels were used: poor compliance (<62.5%) and
good and fair compliance (>62.5%).
Statistical analysis
SPSS version 13 was used. Frequencies, percentages and arith-
metic mean were calculated. Chi-square test and Student’s t
test were used appropriately. A P value <0.05 was considered
signiﬁcant.
Results
The mean age of the studied population was 47.3 (12.46) years.
The mean duration of hypertension was 4.6 (3.07) years.
Most of the women (88.8%) showed poor compliance
(p= 0.000); 86.0% of these had received only basic education,Table 2: Compliance of hypertensive patients with treatment regimen.
Item Level of compliance
Poor
N= 760 %
Periodic medical check-up
Not compliant 554 72.9
Compliant 206 27.1
Periodic electrocardiography and Doppler scan
Not compliant 18 2.4
Compliant 742 97.6
Periodic laboratory investigations
Not compliant 371 48.8
Compliant 389 51.2
Self-measurement of blood pressure
Not compliant 732 96.3
Compliant 28 3.7
Medications
Not compliant 642 84.5
Compliant 118 15.5
Dietary regimen
Not compliant 665 87.5
Compliant 95 12.5
Exercise
Not compliant 719 94.6
Compliant 41 5.4
Total mean score (SD) 30.4 (10.11)
P value <0.05a
a P value of Student’s t test signiﬁcant at <0.05.but 84.7% of those with higher education were also poorly
compliant (p= 0.000) (Table 1). Only 12.4% of the working
population and 13.5% of married participants showed good
compliance (both p= 0.000). Only 9.7% of non-smokers
had fair-to-good compliance, and 83.0% of people with co-
morbid conditions had poor compliance (Table 1).
The total mean percentage score for compliance was 35.1
(14.48), with a signiﬁcant difference between poor and fair-
to-good compliance (p= 0.000) (Table 2) The best compliance
was with periodic electrocardiography and Doppler, followed
by periodic laboratory investigations. The worst compliance
was with exercise (Table 2).
More than two ﬁfths (85.2%) of those who stated that they
could not access the prescribed medications and 80.5% of those
who found that that the delay before obtaining an appointment
was too long also had poor compliance (p= 0.001). Poor com-
pliance was also seen for 80.0% of patients who complained
that their examination was too short (p= 0.000). Fair-to-good
compliance was found for 14.4% of people who had a satisfac-
tory patient–physician relationship (p= 0.015). Most patients
who received supplementary health education materials
(87.8%) had poor compliance (p= 0.009) (Table 3).
The outcomes of care (systolic and diastolic blood pressure,
pulse rate per minute and complications) were signiﬁcantly
poorer for patients with fair-to-good compliance than those
with poor compliance (Table 3). Yes this is result, but not
every point expressed in the result section discussed in discus-
sion but the reverse is true.Mean score
Fair to good
N= 140 %
37 26.4 0.34 (0.48)
103 73.6
6 4.3 1.0 (0.16)
134 95.7
22 15.7 0.56 (0.49)
118 84.3
118 84.3 0.15 (0.22)
22 15.7
57 40.7 0.22 (0.42)
83 59.3
72 51.4 0.18 (0.39)
68 48.6
77 55.0 0.12 (0.32)
63 45.0
60.3 (6.19) 35.1 (14.48)
Table 3: Patients’ satisfaction with quality of care and compliance level.
Level of compliance Total P value
Poor Fair to good
N= 760 % N= 140 % N= 900
Medications
Not available 306 85.2 53 14.8 359 100.0 NS
Available 454 83.9 87 16.1 541 100.0
Waiting time
Long 350 80.5 85 19.5 435 100.0 <0.05a
Reasonable 410 88.2 55 11.8 465 100.0
Examination time
Insuﬃcient 360 80.0 90 20.0 450 100.0 <0.05a
Suﬃcient 400 88.9 50 11.1 450 100.0
Patient–physician relationship
Unsatisfactory 241 82.0 53 18.0 294 100.0 <0.05a
Satisfactory 519 85.6 87 14.4 606 100.0
Health education about: Type of treatment
No 441 82.7 92 17.3 533 100.0 NS
Yes 319 86.9 48 13.1 367 100.0
Proper use of medications
No 449 82.8 93 17.2 542 100.0
Yes 311 86.9 47 13.1 358 100.0 <0.05a
Complications of hypertension
No 457 84.0 87 16.0 544 100.0 NS
Yes 303 85.1 53 14.9 356 100.0
Follow-up schedule
No 351 80.3 86 19.7 437 100.0 <0.05a
Yes 409 88.3 54 11.7 463 100.0
Supplementary health education material
No 387 81.5 88 18.5 475 100.0 <0.05a
Yes 373 87.8 52 12.2 425 100.0
Outcome of care
Systolic blood pressure
Mean (SD)
120.1 (10.59) 115.4 (9.67) 116.2 (8.73) <0.05a
Diastolic blood pressure
Mean (SD)
81.5 (12.34) 80.1 (10.81) 80.5 (9.64) <0.05a
Pulse rate/minute
Mean (SD)
78.5 (5.8) 75.9 (7.61) 77.3 (5.21) <0.05a
Complications
Absent 301 74.9 101 25.1 402 100.0 <0.05a
Present 459 92.2 39 7.8 498 100.0
a Pearson’s chi-square test, p< 0.05; P value of Student’s t test.
13.1%
13.1%
16.7%
21.2%
15.0%
20.9%
Financial
Forgetting
Feel better
No motivation
Frequent micturation
All
Figure 1: Causes of poor compliance with medication.
10.8%
13.4%
28.3%
19.2%
28.3%
Difficulty in changing habit
Financial
Dificulty in preparing specific food
No dietary knowledge
All
Figure 2: Causes of poor compliance with dietary regimen.
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17.6%
14.2%
15.1%
10.4%
20.0%
27.7%
Difficulty in changing habits
No time
Strenuous work
Disabling illness
Lack of knowledge
All
Figure 3: Causes of poor compliance with exercise regimen.
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compliance (21.2%) (Fig. 1). Difﬁculty in preparing a speciﬁc
diet (28.3%) was the most frequent cause of poor compliance
to the dietary regimen (Fig. 2), and 20.0% stated that lack ofTable 4: Patients’ perceptions of hypertension and compliance level.
Level of compliance
Poor Fair
N= 760 % N=
Severity of hypertension
No 595 78.3/83.6 117
Yes 165 21.7/87.8 23
Susceptibility to complications
No 343 45.1/87.7 48
Yes 417 54.9/81.9 92
Impact on social life
No 448 58.9/83.0 92
Yes 312 41.1/86.7 48
Beneﬁts of compliance
No 156 20.5/94.0 10
Yes 604 79.5/82.3 130
Barriers to treatment
No 312 41.1/80.8 74
Yes 448 58.9/87.2 66
Barriers to diet
No 302 39.7/84.4 56
Yes 458 60.3/84.5 84
Barriers to exercise
No 322 42.4/85.4 55
Yes 438 57.6/83.7 85
Internal cues to compliance: control of severe hypertension
No 242 31.8/79.9 61
Yes 518 68.2/86.8 79
External cues to compliance: family support
No 249 32.8/92.2 21
Yes 511 67.2/81.1 119
Educational support
No 387 50.9/81.5 88
Yes 373 49.1/87.8 52
Score: mean (SD) 50.4 (14.18) 75.9
a Pearson’s chi-square test, p< 0.05; P value of Student’s t test.knowledge was the chief cause of non-compliance with the
exercise regime (Fig. 3).
The mean percentage score for patient perceptions concern-
ing hypertension was 65.4 (10.52) (p= 0.002), with the highest
values for beneﬁts of compliance (81.6%) and the role of fam-
ily support (70.0%) (Table 4).
Compliance with a treatment regimen was positively corre-
lated with duration of hypertension (r= 0.066, p= 0.043)
(Fig. 4).
Discussion
This study shows that the worst compliance is with exercise
and dietary regimens and the best with laboratory investiga-
tions, even when hypertension was severe enough to justify
immediate medication. This result concurs with those of simi-
lar studies17,18, even though the achievement and maintenance
of a more optimal standardized weight with a healthful dietary
plan, recommended levels of regular physical activity andTotal P value
to good
140 % N= 900 %
83.6/16.4 712 79.1/100.0 <0.05a
16.4/12.2 188 20.9/100.0
34.3/12.3 391 43.4/100.0 <0.05a
65.7/18.1 509 56.6/100.0
65.7/17.0 540 60.0/100.0 NS
34.3/13.3 360 40.0/100.0
7.1/6.0 166 18.4/100.0 <0.05a
92.9/17.7 734 81.6/100.0
52.9/19.2 386 42.9/100.0 <0.05a
47.1/12.8 514 57.1/100.0
40.0/15.6 358 39.8/100.0 NS
60.0/15.5 542 60.2/100.0
39.3/14.6 377 41.9/100.0 <0.05a
60.7/ 16.3 523 58.1/100.0
43.6/20.1 303 33.7/100.0 <0.05a
56.4/13.2 597 66.3/100.0
15.0/7.8 270 30.0/100.0 <0.05a
85.0/18.9 630 70.0/100.0
62.9/18.5 475 52.8/100.0 <0.05a
37.1/12.2 425 47.2/100.0
(15.23) 65.4 (10.52) <0.05a
20.0015.0010.005.000.00
Duration_of_hypertension
80.00
60.00
40.00
20.00
C
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R Sq Linear = 0.004
r= -.066*, sig.=.043
Figure 4: Relation between duration of hypertension and
compliance.
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reduction in blood pressure.
One limitation of this study is that we did not exclude pa-
tients with psychiatric problems or those with severe complica-
tions with perminant disabling sequlae, such as stroke. This
should be avoided in future studies.
The level of compliance varies from patient to patient. We
found that that sex, educational level, work status, smoking
habits and self-reported response to medications affected com-
pliance, as did patients’ perceptions of hypertension. Other
factors that affect compliance include the recommended
behavioural change, the complexity of the regimen and the
ease with which the patient could incorporate the recommen-
dations into his or her daily routine. Compliance also varies
according to incentive, therapeutic intent or goal and the abil-
ity to pay for care. It is difﬁcult to predict which patients will
comply and to what extent they will comply with a given
behaviour at any time. It has been known for decades that
compliance with lifestyle behaviour change and drug regimens
has been overestimated by both patients and providers.18
Health education is considered the cornerstone of manage-
ment, particularly for hypertensive patients. The rationale for
enhancing compliance is based on the premise that the patient
will get well or stay well if the physician, other health care pro-
viders and health care organizations make appropriate recom-
mendations, provided that the patient has the requisite
knowledge, motivation, skills and resources to follow the rec-
ommendations.16,17 The literature on compliance is dominated
by reports of patient noncompliance with prevention and
treatment recommendations, and there are fewer reports on
how the behaviour of health care professionals and the deliv-
ery of medical care contribute to patient compliance. We also
studied patient satisfaction and found that only 14.4% of pa-
tients with fair-to-good compliance reported a satisfactory pa-
tient–physician relationship. Effective communication between
physician and patient depends in part on the physician’s con-
ﬁdence in his or her ability to teach and enhance patient skills
as well as the time available for providing preventive services.14
The aim of treatment should be reduce blood pressure to
<140/90 mm Hg for most individuals and lower for those with
diabetes or kidney disease.19,20,21 This aim was achieved for
patients in this study, whose mean systolic pressure was
116.2 (8.73) and diastolic pressure was 80.5 (9.64). We foundthat 83.0% of patients with co-morbid conditions had poor
compliance. Such conditions may determine the target blood
pressure, with lower targets for patients with end-organ dam-
age or proteinurea.12,19–22 The results of this study lead us to
suggest that the most appropriate therapeutic attitude in treat-
ing patients with hypertension should be to avoid therapeutic
withdrawal and lack of medical control. In the United States,
only about one third of all people with hypertension are con-
trolled, and programmes to improve hypertension control
rates and prevent hypertension are urgently needed.23
Conclusion
Patients with hypertension were poorly compliant with exer-
cise and dietary regimens. Sex, educational level, work status,
smoking habits and self-reported response to medications af-
fected compliance, as did patients’ perceptions of hyperten-
sion. A minority of patients with fair-to-good compliance
had a satisfactory patient–physician relationship. Most pa-
tients with co-morbid conditions were poorly compliant.
Health promotion programmes should emphasize a healthy
lifestyle, patient education, family counselling and social sup-
port networks in order to enhance compliance with therapeutic
regimens for hypertension and to improve patients’ quality of
life.
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